MA5-14781

antibody from Invitrogen Antibodies

Targeting: RECK hRECK, ST15

Western blot (Data presented on provider website)

Other assay (Supportive data in Antibodypedia)

Antibody Data

Product number

MA5-14781

Provider

Invitrogen Antibodies

Product name

RECK Monoclonal Antibody (F.286.6)

Antibody type

Monoclonal

Antigen

Synthetic peptide

Description

It is not recommended to aliquot this antibody.

Reactivity

Human, Mouse, Rat

Host

Rabbit

Isotype

IgG

Antibody clone number

F.286.6

Vial size

100 µL

Concentration

513 µg/mL

Storage

-20°C

References

Submitted references

Extracellular vesicles secreted by hypoxia pre-challenged mesenchymal stem cells promote non-small cell lung cancer cell growth and mobility as well as macrophage M2 polarization via miR-21-5p delivery.

Ren W, Hou J, Yang C, Wang H, Wu S, Wu Y, Zhao X, Lu C
Journal of experimental & clinical cancer research : CR 2019 Feb 8;38(1):62

Other assay

Supportive validation

Submitted by

Invitrogen Antibodies (provider)

Main image

Experimental details

Fig. 5 miR-21-5p delivery by H-EV treatment promote NSCLC cell proliferation, survival and mobility by targeting PTEN, PDCD4 and RECK. a - d , western blot detecting PTEN, PDCD4 and RECK protein expression level in A549 or H23 cells after different treatment as described in Fig. 4 . e - k , cell functional assay as described in Fig. 1 . A549 or H23 cells with or without PTEN, PDCD4 or RECK gene overexpression (O/E) were tested. Wild type, non-treated A549 or H23 cells were used as negative control (NC). Bar in K indicates 20 mum. Tukey's test was used for statistical analysis. *, p < 0.05; **, p < 0.01; ***, p < 0.001; ****, p < 0.0001